| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910829938603321 |
|
|
Autore |
Geis George T. |
|
|
Titolo |
Semi-organic growth + website : tactics and strategies behind Google's success / / George T. Geis |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, New Jersey : , : Wiley, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-118-93323-0 |
1-119-01504-9 |
1-118-93324-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (243 p.) |
|
|
|
|
|
|
Classificazione |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Consolidation and merger of corporations |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Machine generated contents note: Preface Acknowledgments Chapter 1: M&A Success and Failure Chapter 2: Imprinting Semi-organic Growth Chapter 3: Google v. Apple: M&A Paths Diverge, then Converge Chapter 4: M&A Market Modeling Chapter 5: Google Media Deals Chapter 6: Google Internet Deals Chapter 7: Google Technology Platform Deals Chapter 8: Failed or Shuttered Deals Chapter 9: Disclosure versus Secrecy Chapter 10: Forms of Consideration Chapter 11: Contingent Consideration Chapter 12: Dimensions of M&A Integration and Semi-organic Growth Chapter 13: Acqui-hires Enhancing Google Offerings Chapter 14: Competitive Deal Constellations and Ecosystem Synergy References About the Website About the Author Index . |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"An in-depth examination of Google's innovative approach to M&A Semi-Organic Growth presents a unique analysis of Google's distinctive expertise in the area of mergers and acquisitions, derived from more than 150 acquisitions carried out over the company's short history. While organizational growth has traditionally been characterized as organic (internally generated) or inorganic (from acquisition), this book examines Google's semi-organic strategy for accelerating product and service revenue, explained through a unique sector/subsector classification scheme that dynamically maps the media, Internet, and |
|
|
|
|
|
|
|
|
|
|
technology platform markets. You'll gain insight into Google's disclosure strategies for private company transactions, and more importantly, their methods for integrating acquisitions into product and service offerings to achieve ecosystem synergy. Unique perspective reveals the lessons learned along the way from both successes and failures, and the companion website gives you access to the tools that help you implement what you've learned. Google's extensive use of M&A as a growth strategy has been in sharp contrast to the practices of rivals like Apple, and further contrasts with the failures of many other companies in corporate business development. This book shows you the thinking behind the company's successful methods, and demonstrates the mechanisms behind the success. Learn why corporate M&A activity often fails to add value Delve deep into the complex dimensions of M&A integration Discover what Google has learned through specific deals Consider innovative integration methods that foster synergy Google is an iconic, premiere company, and it didn't happen by accident. Their success is driven by their innovative approach to strategy in all areas, and their M&A expertise has been a major contributing factor. Semi-Organic Growth takes you through the core workings of Google M&A to provide insight into successful strategy for the modern market"-- |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910349444703321 |
|
|
Titolo |
Chagas Disease : A Clinical Approach / / edited by Jaime Marcelo Altcheh, Hector Freilij |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2019.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (XII, 356 p. 48 illus., 34 illus. in color.) |
|
|
|
|
|
|
Collana |
|
Birkhäuser Advances in Infectious Diseases, , 2504-3811 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Molecular biology |
Parasitology |
Infectious diseases |
Molecular Medicine |
Infectious Diseases |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Overview -- Chapter 1: Chagas disease: past, present and future -- The agent -- Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell -- Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection -- Epidemiology -- Chapter 4: Epidemiology of Chagas Disease -- Chapter 5: Chagas Disease in Europe -- Chapter 6: Chagas Disease in the United States (USA) -- Diagnosis -- Chapter 7: Diagnosis of Chagas disease -- Clinical aspects -- Chapter 8: Acute vector-borne Chagas disease -- Chapter 9: Congenital Chagas Disease -- Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty -- Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection -- Chapter 12: Gastrointestinal Chagas Disease -- Chapter 13: Chagas in immunosuppressed patients -- Treatment -- Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE -- Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection -- Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected worldwide. It is primarily transmitted by insect vectors that carry the parasite Trypanosoma cruzi, the disease agent. In areas where there is vector control and in non-endemic countries, it is mainly transmitted via congenital infection. Cardiac and gastrointestinal complications are common in untreated individuals.This book offers a comprehensive overview of Chagas disease, including its vectorial and congenital transmission, and molecular diagnosis, which is essential for screening, and developing and providing timely, effective anti-trypanosomal treatment. Written by experts working with infected patients on a daily basis, it discusses the pathogenesis of congenital, cardiac, gastrointestinal and oral Chagas disease, as well as its treatment and the pharmacological aspects of drug development in this area. The chapter, ‘Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities’ is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com. |
|
|
|
|
|
|
|
| |